poisar

Stocks · News reference

Clene Says Post Hoc Analyses Show CNM-Au8-Treated ALS Patients With NfL Decline Or Stabilization Had 38% Lower Risk Of Death vs. Controls In HEALEY; NDA Planned For Early Q4

BenzingaBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Clene Inc. (CLNN)

    Filed: 2026-08-14 AccNo: 0001437749-26-027837 Size: 349 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits